Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -31.501% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] CC1CC(=O)N(CC(=O)NC2CCCCC2)c2ccccc2S1
[b] CC1(C)CC(=O)C(C2c3ccccc3S(=O)(=O)c3ccccc32)C(=O)C1
[c] Cc1ccsc1C(=O)OCC(=O)NC1CCCC1
[d] CCN1CCN(c2nc3sc4c(c3c3ncnn23)CC(C)CC4)CC1
Answer: d. CCN1CCN(c2nc3sc4c(c3c3ncnn23)CC(C)CC4)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2nc3sc4c(c3c3ncnn23)CC(C)CC4)CC1
CCN1CCN(c2nc3sc4c(c3c3ncnn23)CC(C)CC4)CC1
7-(4-ethylpiperazin-1-yl)-14-methyl-10-thia-3,5,6,8-tetrazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2,4,7,11(16)-pentaene